Atlas Trials

Clinical High and Genomic Low Hormone Receptor-positive Early Breast Cancer Patients With or Without Adjuvant Chemotherapy

Clinical trial NCT04278469 · RECRUITING

Trial details

NCT number
NCT04278469
Sponsor
Gencurix, Inc.
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Early Hormone Receptor-positive Breast Cancer
Start date
2019-01-11
Primary completion
2029-01-01
Enrollment
194

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.